Eva Maria Javier Delmo1, Mariano Francisco Del Maria Javier2, Dietmar Böthig3, Andre Rüffer4, Robert Cesnjevar5, Michael Dandel6, Roland Hetzer2. 1. Charité-Universitätsmedizin Berlin, Charité Research Organization, Berlin, Germany. 2. Department of Cardiothoracic and Vascular Surgery, Cardio Centrum Berlin, Berlin, Germany. 3. Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany. 4. Department of Pediatric Cardiology/Pediatric Cardiac Surgery, Universitäres Herzzentrum Hamburg GmbH, Hamburg, Germany. 5. Department of Cardiothoracic and Vascular Surgery, University Medical Center Erlangen, Erlangen, Germany. 6. Department of Cardiology, Cardio Centrum Berlin, Berlin, Germany.
Abstract
BACKGROUND: Data on ventricular unloading-promoted myocardial recovery and post-weaning outcome in children is scarce. We analyzed the weaning outcome in children with heart failure (HF) supported with ventricular assist device (VAD). METHODS: A multi-institutional data on VAD implanted in 193 children and adolescents with HF between April 1990 and November 2015 was reviewed. Among them, 25 children (mean age 3.4±3.0, range, 0.058-16.3 years, 15 females) were weaned from VAD. Etiology of HF were myocarditis (n=11), dilated cardiomyopathy (DCMP) (n=7), ischemic HF (n=3), arrhythmogenic CMP (n=1), post-correction of congenital heart disease (CHD) (n=1) and acute graft failure (n=1). Mean duration of HF before VAD implantation was 59.4±3 days. RESULTS: Age, duration of HF, DCMP, cardiac arrest and duration of VAD are essential clinical characteristics to delineate who may have the potential to myocardial recovery. Echocardiographic parameters pre-implantation, during the final off-pump trial and during the post-explantation follow-ups revealed that LVEF, LVEDD and relative wall thickness (RWT) showed significant differences (P<0.001) among patients stratified by outcome to assess recovery. Presently, 21 (84.0%) of the weaned patients are alive with their native hearts 1.3-19.1 years after VAD explantation. An additional weaned patient had HF recurrence 3 months post-weaning and was transplanted. CONCLUSIONS: Post-weaning myocardial recovery and cardiac stability of children with HF from several etiologies supported with a VAD appears sustainable and durable. Young patients with short HF duration are more likely to recover. Absence of cardiac arrest, cardiac size, geometry and function may prospectively identify patients who may be likely to have myocardial recovery. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.
BACKGROUND: Data on ventricular unloading-promoted myocardial recovery and post-weaning outcome in children is scarce. We analyzed the weaning outcome in children with heart failure (HF) supported with ventricular assist device (VAD). METHODS: A multi-institutional data on VAD implanted in 193 children and adolescents with HF between April 1990 and November 2015 was reviewed. Among them, 25 children (mean age 3.4±3.0, range, 0.058-16.3 years, 15 females) were weaned from VAD. Etiology of HF were myocarditis (n=11), dilated cardiomyopathy (DCMP) (n=7), ischemic HF (n=3), arrhythmogenic CMP (n=1), post-correction of congenital heart disease (CHD) (n=1) and acute graft failure (n=1). Mean duration of HF before VAD implantation was 59.4±3 days. RESULTS: Age, duration of HF, DCMP, cardiac arrest and duration of VAD are essential clinical characteristics to delineate who may have the potential to myocardial recovery. Echocardiographic parameters pre-implantation, during the final off-pump trial and during the post-explantation follow-ups revealed that LVEF, LVEDD and relative wall thickness (RWT) showed significant differences (P<0.001) among patients stratified by outcome to assess recovery. Presently, 21 (84.0%) of the weaned patients are alive with their native hearts 1.3-19.1 years after VAD explantation. An additional weaned patient had HF recurrence 3 months post-weaning and was transplanted. CONCLUSIONS: Post-weaning myocardial recovery and cardiac stability of children with HF from several etiologies supported with a VAD appears sustainable and durable. Young patients with short HF duration are more likely to recover. Absence of cardiac arrest, cardiac size, geometry and function may prospectively identify patients who may be likely to have myocardial recovery. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.
Authors: Eva Maria Delmo Walter; Vladimir Alexi-Meskishvili; Michael Huebler; Matthias Redlin; Wolfgang Boettcher; Yuguo Weng; Felix Berger; Roland Hetzer Journal: Interact Cardiovasc Thorac Surg Date: 2011-03-22
Authors: Michael Dandel; Yuguo Weng; Henryk Siniawski; Evgenij Potapov; Hans B Lehmkuhl; Roland Hetzer Journal: Circulation Date: 2005-08-30 Impact factor: 29.690
Authors: Gopal K R Soppa; Joon Lee; Mark A Stagg; Urszula Siedlecka; Samuel Youssef; Magdi H Yacoub; Cesare M N Terracciano Journal: J Heart Lung Transplant Date: 2008-06-25 Impact factor: 10.247
Authors: M G Gagliardi; M Bevilacqua; C Squitieri; R Boldrini; D P Di Julio; C Marcelletti Journal: J Heart Lung Transplant Date: 1993 Nov-Dec Impact factor: 10.247
Authors: Yitschak Biton; Ilan Goldenberg; Valentina Kutyifa; Jayson R Baman; Scott Solomon; Arthur J Moss; Barbara Szepietowska; Scott McNitt; Bronislava Polonsky; Wojciech Zareba; Alon Barsheshet Journal: J Am Coll Cardiol Date: 2016-01-26 Impact factor: 24.094